Our results indicated that a high ratio of IL32 expression to pericyte marker expression, such as MCAM, PDGFRB, or ACTA2, was also linked to poor overall survival in NSCLC patients (Figure S1O, Supporting Information). Here, PDGFRB is linked to non-small cell lung carcinoma.